Market conditions are Mildly bullish in a Bear Market as of 2023-01-20. This means traders and investors should consider trading with a Neutral or Bullish bias by buying stocks and setting tight stops. The rank of the Bear Market is -11.64 which indicates the current market conditions are Extreme, Risk of a reversal is high. […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $18.7200 0.1700 % 0.9200 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 0.92% […]
Read MoreCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. CTIC $6.0100 0.2200 % 3.8000 Cti Biopharm Corp Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 3.8% Wk: 5.44% Mo: […]
Read MoreStevanato Group S.p.A. (STVN) Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. Collegium Pharmaceutical, Inc. (COLL) […]
Read MoreMarket conditions are Mildly bullish in a Bear Market as of 2022-12-12. This means traders and investors should consider trading with a Neutral or Bullish bias by buying stocks and setting tight stops. The rank of the Bear Market is -14.11 which indicates the current market conditions are Extreme, Risk of a reversal is high. […]
Read MoreUnited Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. UTHR $278.4200 -2.0100 % -0.7200 United Therapeutic Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $16.7600 -0.0600 % -0.3600 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: -0.36% […]
Read MoreCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTIC $5.7600 0.2000 % 3.6000 Cti […]
Read MoreSIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA $9.7000 0.3100 % 3.3000 Siga Technologies Inc Sector : Medical Industry : Medical […]
Read MoreMarket conditions are Bullish in a Bear Market as of 2022-11-08. This means traders and investors should consider trading with a Neutral or Bullish bias by buying stocks and setting tight stops. The rank of the Bear Market is -19.97 which indicates the current market conditions are Extreme, Risk of a reversal is high. The […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. CPRX $14.0600 […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $13.9000 0.5000 % 3.7300 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 3.73% […]
Read MoreCorcept Therapeutics Incorporated (CORT) Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia. Relmada Therapeutics, Inc. (RLMD) Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on […]
Read MoreRelmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017). RLMD $35.0400 1.8100 % 5.4500 Relmada Therapeutics Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long […]
Read More